Importantly, Kaplan–Meier analysis of PC patients who received 5-FU treatment after surgery revealed that low lncRNA FOXD1-AS1 expression was associated with longer survival time after 5-FU therapy (Fig. 5C). The gene discussed is FOXD1; the disease is pachyonychia congenita.